658-48-0Relevant articles and documents
CRYSTALLINE FORMS OF METYROSINE
-
Paragraph 0147, (2022/01/12)
The disclosure provides crystalline compositions comprising D-metyrosine and L-metyrosine, pharmaceutical formulation comprising one or more crystalline composition described herein and a pharmaceutically acceptable excipient, methods for treating cancer in a patient in need thereof, the method comprising administering to the patient one or more composition described herein, and methods for preparing the compositions described herein.
Thyromimetics. V. The synthesis and biological screening of alpha-methylthyroxine.
Blank,Rice,Pfeiffer,Greenberg
, p. 10 - 15 (2007/10/06)
-